米国企業
PRESSURE BIOSCIENCES INC

PRESSURE BIOSCIENCES INCPBIO

時価総額

$254.9万

PER

	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Cash and cash equivalents	1,461	31,417	473,948	116,783	138,363	81,033	103,118	29,625	18,540	132,311	3,865
Accounts receivable	216,265	147,635	272,022	113,256	281,320	206,848	474,830	229,402	131,228	154,746	295,374
Inventories, net of $982,973 and $342,496 reserve, respectively	923,362	736,676	850,552	1	905,284	857,662	765,478	617,716	592,767	1	686,383
Prepaid expenses and other current assets	83,435	85,573	104,204	213,926	258,103	214,676	170,734	213,549	314,936	422,617	257,527
Total current assets	1	1	2	1	2	1	2	1	1	2	1
Investment in equity securities	-	-	-	-	-	-	16,643	16,643	517,001	59,976	63,638
Property and equipment, net	30,282	58,102	36,025	20,149	9,413	22,662	69,272	55,590	16,490	115,846	103,351
Right of use asset operating leases	-	-	-	-	-	-	-	76,586	221,432	395,565	282,095
Intangible assets, net	85,130	36,498	-	-	-	750,000	663,462	576,923	490,385	403,846	317,308
TOTAL ASSETS	1	1	2	2	2	2	2	2	2	3	2
Accounts payable	1	1	1	941,389	407,249	589,263	658,856	815,764	771,945	527,924	637,238
Accrued employee compensation	119,338	149,333	157,347	176,009	249,596	368,700	456,932	451,200	417,578	117,680	167,247
Accrued professional fees and other	-	-	-	-	-	-	-	-	2	2	2
Accrued interest and dividends payable	-	-	-	-	-	-	-	-	-	-	11
Deferred revenue	46,466	28,189	27,117	140,878	159,654	263,106	-	-	47,328	37,124	58,242
Convertible debt, net of unamortized debt discounts of $455,517 and $1,536,649, respectively	-	-	-	100,000	4	8	4	6	8	13	18
Other debt, net of unamortized discounts of $0 and $0, respectively	-	-	-	151,628	238,157	1	852,315	2	1	1	2
Related party debt, net of unamortized debt discount of $7,915 and $0, respectively	98,675	-	-	-	-	-	-	-	-	-	634,885
Right of use operating lease liability	-	-	-	-	-	-	-	76,586	65,193	132,996	142,171
Total current liabilities	3	3	4	10	9	17	8	14	19	25	34
Long term debt	-	-	-	-	-	-	-	-	527,039	150,000	150,000
Right of use operating lease liability long term	-	-	-	-	-	-	-	-	156,239	262,569	139,924
Deferred revenue	2,487	2,785	28,977	36,935	87,527	57,149	37,757	18,065	19,382	3,587	1,822
TOTAL LIABILITIES	3	3	4	10	10	17	9	14	19	25	35
Series D, G, H, H2, J, K, AA Convertible Preferred Stock, $.01 par value (Note 10)	-	-	-	-	-	-	-	-	-	-	1,098
Common stock, $.01 par value; 100,000,000 shares authorized; 13,682,910 and 9,120,526 shares issued and outstanding on December 31, 2022 and December 31, 2021, respectively	121,493	120,243	186,734	230,050	309,998	13,429	16,842	25,496	41,683	91,206	136,829
Warrants to acquire common stock	-	-	-	-	-	-	-	-	-	-	32
Additional paid-in capital	16	20	25	26	27	31	40	44	50	64	69
Accumulated deficit	-20,619,539	-25,866,988	-32,118,714	-39,557,206	-42,264,190	-55,349,299	-65,727,538	-78,942,277	-96,465,807	-118,277,468	-133,826,205
TOTAL STOCKHOLDERS’ DEFICIT	-1,539,776	-1,967,775	-2,059,731	-7,977,648	-8,383,418	-14,622,796	-6,125,071	-12,055,407	-16,917,592	-22,208,961	-32,686,371
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	1	1	2	2	2	2	2	2	2	3	2